Margaret Macro
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Hematology 53
- Multiple Myeloma Research and Treatments 47
- Oncology 32
- Cancer Treatment and Pharmacology 13
- Peptidase Inhibition and Analysis 10
- Co-authors
- Gérald Marit (3 shared papers)Hervé Tilly (4 shared papers)Bertrand Coiffier (4 shared papers)Dominique Bordessoule (2 shared papers)Karim Belhadj (9 shared papers)Sylvie Castaigné (3 shared papers)Catherine Thiéblemont (4 shared papers)Christophe Fermé (3 shared papers)
- Journals
- Blood (23 papers)Journal of Clinical Oncology (12 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Thrombosis Research (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Margaret Macro
82 papers receiving 3.6k citations
Margaret Macro's Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 1.6k
- Pathology and Forensic Medicine 1.2k
- Oncology 1.5k
- Genetics 537
- Neurology 448
Countries citing papers authored by Margaret Macro
This map shows the geographic impact of Margaret Macro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Macro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Macro more than expected).
Fields of papers citing papers by Margaret Macro
This network shows the impact of papers produced by Margaret Macro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Macro. The network helps show where Margaret Macro may publish in the future.
Co-authors
The 25 scholars most cited alongside Margaret Macro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Hit paper breakdown → | 2010 | 1083 |
| 2 | 1998 | 387 | |
| 3 | 2010 | 302 | |
| 4 | 2005 | 287 | |
| 5 | 2003 | 191 | |
| 6 | 2009 | 167 | |
| 7 | 2020 | 90 | |
| 8 | 2006 | 90 | |
| 9 | 2016 | 77 | |
| 10 | 2015 | 76 | |
| 11 | 2004 | 48 | |
| 12 | 2004 | 46 | |
| 13 | 2014 | 43 | |
| 14 | Septic arthritis of lumbar facet joints. A review of six cases. | 1997 | 40 |
| 15 | 2024 | 32 | |
| 16 | 2000 | 32 | |
| 17 | 2000 | 32 | |
| 18 | A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. | 1998 | 32 |
| 19 | 1995 | 30 | |
| 20 | Transforming growth factor-beta (TGF-beta) and articular chondrocytes. | 1994 | 29 |
About Margaret Macro
Margaret Macro is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 85 papers that have together received 3.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (47 papers), Cancer Treatment and Pharmacology (13 papers), Protein Degradation and Inhibitors (12 papers), Peptidase Inhibition and Analysis (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Hematology (1.6k citations), Pathology and Forensic Medicine (1.2k citations), Oncology (1.5k citations), Genetics (537 citations) and Neurology (448 citations). Margaret Macro has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Gérald Marit, Hervé Tilly, Bertrand Coiffier, Dominique Bordessoule, Karim Belhadj, Sylvie Castaigné, Catherine Thiéblemont, Christophe Fermé, Éric Van Den Neste and Sophie Lefort. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.